| hsa04110: cell cycle |
1.24E-10 |
E2F1, CDC7, CDC6, RBL1, CDK6, SMAD2, RBX1, CDKN1C, CCND1, CDKN2A, CCNA2, STAG2, TFDP1
|
| hsa04350: TGF-beta signaling pathway |
3.50E-06 |
SMAD7, TGFBR2, RBL1, SMAD2, THBS1, PITX2, RBX1, TFDP1
|
| hsa05212: pancreatic cancer |
1.43E-04 |
E2F1, CCND1, CDKN2A, TGFBR2, SMAD2, CDK6
|
| hsa05220: chronic myeloid leukemia |
0.002351 |
E2F1, CCND1, CDKN2A, TGFBR2, CDK6
|
| hsa05219: bladder cancer |
0.003949 |
E2F1, CCND1, CDKN2A, THBS1
|
| hsa04390: hippo signaling pathway |
0.00635 |
CCND1, TGFBR2, SOX2, WWC1, SMAD2, YAP1
|
| hsa05206: microRNAs in cancer |
0.006607 |
RECK, E2F1, SPRY2, CCND1, CDKN2A, CDK6, THBS1, PDCD4
|
| hsa05223: non-small cell lung cancer |
0.009453 |
E2F1, CCND1, CDKN2A, CDK6
|
